Hepatic Hemangioma · Observe vs Resection

Step-by-step decision

Choose step by step as prompted; reaching an endpoint gives the management recommendation. You can go back a step or restart anytime.

🎓 Want to practice? Do a case challenge with this pathway → (get a case, choose management step by step, scored).

Full pathway

1. [Decision] Size/symptoms/diagnostic certainty/complications
   Symptoms? Size/growth? Diagnosis clear? Complications?
   • Asymptomatic, clear diagnosis (typical imaging) → Asymptomatic typical → observe
   • Symptomatic (compression/pain) / giant and progressively enlarging / uncertain diagnosis → Symptomatic/giant/uncertain → resection/enucleation
   • Kasabach-Merritt (consumptive coagulopathy) / rupture with bleeding → Kasabach-Merritt/rupture → emergency
2. [End] Asymptomatic typical → observe
   Asymptomatic, typical imaging → observe and follow up (no malignant potential, rupture is rare); most need no treatment.
3. [End] Symptomatic/giant/uncertain → resection/enucleation
   Symptomatic/giant progressively enlarging/uncertain diagnosis (cannot exclude malignancy) → surgical resection or enucleation (along the pseudocapsule, preserving liver parenchyma); embolization is an alternative (preoperative volume reduction/unfit for surgery).
4. [End] Kasabach-Merritt/rupture → emergency
   Kasabach-Merritt phenomenon (thrombocytopenia/consumptive coagulopathy) or rupture with bleeding → emergency management (embolization/surgery) + correct coagulopathy.

Source guidelines & references

• Hepatic hemangioma management (mostly observation; surgical indications and enucleation)

This pathway is our own synthesis of the decision logic in the guidelines above (not the guideline verbatim); thresholds and workflows change as guidelines update — in practice follow the latest guideline, your institution's protocol and the individual patient.

Other pathways